RE:Pancreatic cancer data a game changer for this stockI agree, the Panc cancer ( goblet with Roche), is a game changer.
In my 20+ yrs of following Onc, this has been the most positive outcome.
I strongly recommend everyone, new old or just thinking about owning Onc shares, log into
oncolytics biotech & listen to the conference call.
first time ever, that I can recall...the B.D. Guy acknowledged they have had multiple offers, yet are waiting for a more favourable deal.
At the 19:20 time or so, they discuss multiple discussions with multiple potential partners , something like that.
most importantly, they were extremely clear. If the remaining panc resukts are as good as the first, they will be Persuing a second phase 3 trial.
THAT data etc will be public before the end of this year.
please don't take my word. Go & listen,.
or on Alpha trader, there is a published transcript.